CanaQuest Medical Corp. is a pharmaceutical company, which is focused on the medical cannabis products, utilizing cannabinoid molecules, and other botanical compounds. The firm as developed Mentanine, Omega3 compounds + CBD pharma grade isolate, which is used for mental health issues inside the central nervous system and Mentabinol, THC + L-Theanine formulation, which is an alternative to all other THC products, addressing anxiety, depression, schizophrenia, and post traumatic stress disorder. The company was founded by Paul Ramsay and Richard J. Rusiniak on October 7, 2008 and is headquartered in Mississauga, Canada.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company